focus -WSS

focus

author：comprehensive 2025-10-01 17:35:34 - browse：3

Illustration of a dollar sign with arrows. — Adobe

Health insurers are telling shareholders that they are ramping up the use of artificial intelligence and are hiring talent to implement the technology across their organizations. They say their artificial intelligence models can increase efficiency and “cut costs,” but they refused to discuss what models they’re using, how those models were developed, or exactly what they’re using them for.

Centene, for instance, says, it is “investing in artificial intelligence and machine learning technologies to improve the health of our members and contain rising healthcare costs.” The insurer, whose plans cover more than 28 million Americans, noted that its large footprint, particularly in government-sponsored programs, puts it “in a unique position to use data to develop models that predict a wide range of health outcomes.”

A STAT review of regulatory filings from publicly traded health insurers showed that several of them, including Elevance, Molina, and Cigna, are investing in AI with the goal of saving money. Elevance has hired nearly 500 people to work exclusively on AI. However, all five of the insurers STAT contacted declined to elaborate on how they are using AI.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Maui wildfire now ranks as the fifth

WSS

The science behind Janet Jackson's pregnancy at 49

Why drug prescriptions should include diagnoses

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

What to know about the judge who will handle the Trump case

Paxlovid study fails to answer questions over benefit for broader groups

Paxlovid study fails to answer questions over benefit for broader groups

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Trump demands the U.S. pay no more for drugs than other countries … again

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

United colonoscopy coverage change 'may cost lives,' doctors say

The science behind Janet Jackson's pregnancy at 49

Trump demands the U.S. pay no more for drugs than other countries … again

Dozens dead from Maui wildfires: What we know about the victims

BioMarin wins approval for gene therapy to treat hemophilia A

Novo Nordisk touts Wegovy study, but still struggling with supply

Supreme Court strikes down use of affirmative action

What would happen to your eyes if you looked at the solar eclipse?

hotspot

Biogen’s boardroom scandal saddles CEO with first crisis

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Schizophrenia gene found to be linked to cells' energy dysfunction

Montana youths win climate lawsuit against state for promoting fossil fuels

The battle over the Brookhaven Landfill on Long Island

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

knowledge

knowledge

hotspot

hotspot